These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32643137)

  • 1. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2.
    Le Voyer T; Boutboul D; Ledoux-Pilon A; de Fontbrune FS; Boursier G; Latour S; Le Guenno G
    J Clin Immunol; 2020 Aug; 40(6):948-953. PubMed ID: 32643137
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
    Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
    J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
    [No Abstract]   [Full Text] [Related]  

  • 3. ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype.
    Ferriani MPL; Valera ET; de Sousa GR; Sandrin-Garcia P; de Moura RR; Hershfield MS; de Carvalho LM
    Rheumatology (Oxford); 2021 Jul; 60(7):e237-e239. PubMed ID: 33493352
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2).
    Cooray S; Omyinmi E; Hong Y; Papadopoulou C; Harper L; Al-Abadi E; Goel R; Dubey S; Wood M; Jolles S; Berg S; Ekelund M; Armon K; Eleftheriou D; Brogan PA
    Rheumatology (Oxford); 2021 Sep; 60(9):4373-4378. PubMed ID: 33420503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.
    Poswar Fde O; da Fonseca RM; de Albuquerque LC; Zhou Q; Jardim LB; Monte TL; Aksentijevich I; Saute JA
    J Neurol; 2016 Apr; 263(4):818-20. PubMed ID: 26914925
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
    Hashem H; Egler R; Dalal J
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of EBV Related Diffuse Large B-cell Lymphoma in Deficiency of Adenosine Deaminase 2 with Uncontrolled EBV Infection.
    Gardner LS; Vaughan L; Avery DT; Meyts I; Ma CS; Tangye SG; Varikatt W; Lin MW
    J Clin Immunol; 2024 May; 44(5):118. PubMed ID: 38758417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
    Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
    [No Abstract]   [Full Text] [Related]  

  • 10. Warts and DADA2: a Mere Coincidence?
    Arts K; Bergerson JRE; Ombrello AK; Similuk M; Oler AJ; Agharahimi A; Mace EM; Hershfield M; Wouters C; De Somer L; Morren MA; Diego RP; Moens L; Freeman AF; Meyts I
    J Clin Immunol; 2018 Nov; 38(8):836-843. PubMed ID: 30386947
    [No Abstract]   [Full Text] [Related]  

  • 11. Teaching NeuroImages: Lacunar stroke and polyarteritis nodosa: Consider ADA2 deficiency (DADA2).
    Gonçalves TDS; Alves CAPF; da Paz JA; Lucato LT
    Neurology; 2019 Apr; 92(15):e1801-e1802. PubMed ID: 30962308
    [No Abstract]   [Full Text] [Related]  

  • 12. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.
    Schena F; Penco F; Volpi S; Pastorino C; Caorsi R; Kalli F; Fenoglio D; Salis A; Bertoni A; Prigione I; Bocca P; Insalaco A; De Benedetti F; Antonini F; Grossi A; Signa S; Damonte G; Ceccherini I; Filaci G; Traggiai E; Gattorno M
    Eur J Immunol; 2021 Jan; 51(1):206-219. PubMed ID: 32707604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.
    Kisla Ekinci RM; Balci S; Hershfield M; Bisgin A; Dogruel D; Altintas DU; Yilmaz M
    Rheumatology (Oxford); 2020 Jan; 59(1):254-256. PubMed ID: 31292637
    [No Abstract]   [Full Text] [Related]  

  • 15. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.
    Rama M; Duflos C; Melki I; Bessis D; Bonhomme A; Martin H; Doummar D; Valence S; Rodriguez D; Carme E; Genevieve D; Heimdal K; Insalaco A; Franck N; Queyrel-Moranne V; Tieulie N; London J; Uettwiller F; Georgin-Lavialle S; Belot A; Koné-Paut I; Hentgen V; Boursier G; Touitou I; Sarrabay G
    Eur J Hum Genet; 2018 Jul; 26(7):960-971. PubMed ID: 29681619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of deficiency of adenosine deaminase 2 caused by CECR1 mutation with myeloablative hematopoietic stem cell transplantation].
    Song XC; Zhou F
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):509-511. PubMed ID: 32521966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.
    Lee PY; Huang Y; Zhou Q; Schnappauf O; Hershfield MS; Li Y; Ganson NJ; Sampaio Moura N; Delmonte OM; Stone SS; Rivkin MJ; Pai SY; Lyons T; Sundel RP; Hsu VW; Notarangelo LD; Aksentijevich I; Nigrovic PA
    J Allergy Clin Immunol; 2018 Oct; 142(4):1363-1365.e8. PubMed ID: 29936104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenosine deaminase 2 deficiency: a disease with multiple presentations].
    Caratsch L; Schnider C; Moi L; Theodoropoulou K; Candotti F; Hofer M
    Rev Med Suisse; 2022 Apr; 18(776):669-673. PubMed ID: 35385618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous Splice ADA2 Gene Mutation Causing ADA-2 Deficiency.
    Chong-Neto HJ; Segundo GRS; Bandeira M; Chong-Silva DC; Rosário CS; Riedi CA; Hershfield MS; Ochs H; Torgerson T; Rosário NA
    J Clin Immunol; 2019 Nov; 39(8):842-845. PubMed ID: 31617030
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
    Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
    J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.